Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CureScience is a San Diego-based 501(c)(3) life sciences research institute operating under the legal name Brain Cancer Research Institute. The organization focuses on precision medicine, regenerative medicine, immunology, neurology, diagnostics, and translational research intended to accelerate discovery and commercialization of novel therapeutics and diagnostics. Its activities appear to center on research programs, technical services, bioinformatics and artificial intelligence-enabled analysis, immune profiling, and patient engagement rather than a disclosed conventional clinical-stage drug pipeline. CureScience has particular historical roots in brain cancer, especially glioblastoma, and has described work spanning cancer, neurological disease, autoimmune disease, and COVID-19-related programs. The institute also collaborates with academia and industry and runs educational bioinformatics programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CureScience Institute.